JPWO2020104676A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020104676A5
JPWO2020104676A5 JP2021529003A JP2021529003A JPWO2020104676A5 JP WO2020104676 A5 JPWO2020104676 A5 JP WO2020104676A5 JP 2021529003 A JP2021529003 A JP 2021529003A JP 2021529003 A JP2021529003 A JP 2021529003A JP WO2020104676 A5 JPWO2020104676 A5 JP WO2020104676A5
Authority
JP
Japan
Prior art keywords
cells
cell
artificial
car
artificial feeder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021529003A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513116A (ja
JP2022513116A5 (https=
JP7450892B2 (ja
Publication date
Priority claimed from EP18208092.9A external-priority patent/EP3656851A1/en
Application filed filed Critical
Publication of JP2022513116A publication Critical patent/JP2022513116A/ja
Publication of JP2022513116A5 publication Critical patent/JP2022513116A5/ja
Publication of JPWO2020104676A5 publication Critical patent/JPWO2020104676A5/ja
Application granted granted Critical
Publication of JP7450892B2 publication Critical patent/JP7450892B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021529003A 2018-11-23 2019-11-22 Ｎｋ細胞のための人工ｈｌａ陽性フィーダー細胞株及びその使用 Active JP7450892B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18208092.9A EP3656851A1 (en) 2018-11-23 2018-11-23 Artificial hla-positive feeder cell lines for nk cells and uses thereof
EP18208092.9 2018-11-23
PCT/EP2019/082283 WO2020104676A1 (en) 2018-11-23 2019-11-22 Artificial hla-positive feeder cell lines for nk cells and uses thereof

Publications (4)

Publication Number Publication Date
JP2022513116A JP2022513116A (ja) 2022-02-07
JP2022513116A5 JP2022513116A5 (https=) 2022-09-30
JPWO2020104676A5 true JPWO2020104676A5 (https=) 2022-09-30
JP7450892B2 JP7450892B2 (ja) 2024-03-18

Family

ID=64664021

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021529003A Active JP7450892B2 (ja) 2018-11-23 2019-11-22 Ｎｋ細胞のための人工ｈｌａ陽性フィーダー細胞株及びその使用

Country Status (5)

Country Link
US (1) US11578307B2 (https=)
EP (2) EP3656851A1 (https=)
JP (1) JP7450892B2 (https=)
CA (1) CA3119403C (https=)
WO (1) WO2020104676A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018060351A1 (en) * 2016-09-29 2018-04-05 Ipsen Biopharm Limited Hybrid neurotoxins
EP3746095A4 (en) 2018-02-01 2021-04-21 Nkmax Co., Ltd. Method of producing natural killer cells and composition for treating cancer
KR20220095228A (ko) * 2019-11-06 2022-07-06 베이롤 칼리지 오브 메드신 암의 t 세포 치료를 위한 세포독성 효과기 기억 t 세포를 생산하는 방법
EP4163366A4 (en) * 2020-06-09 2024-08-21 Samsung Life Public Welfare Foundation GENETICALLY MODIFIED CELL LINE FOR ACTIVATION AND AMPLIFICATION OF NK CELLS AND USE THEREOF
CN112048482A (zh) * 2020-09-09 2020-12-08 广东昭泰体内生物医药科技有限公司 一种nk样细胞的培养方法
US12264184B2 (en) * 2021-02-23 2025-04-01 H. Lee Moffitt Cancer Center And Research Institute, Inc. DAP12 constructs and their use to enhance DC vaccines and immunotherapies
US20230149464A1 (en) * 2021-11-18 2023-05-18 Janssen Biotech, Inc. Feeder free cell culture methods for expanding natural killer cell preparations
WO2023096352A1 (ko) * 2021-11-25 2023-06-01 사회복지법인 삼성생명공익재단 Hla-e를 발현하도록 유전적으로 조작된 배양보조세포주, 및 그의 용도
CN117343906A (zh) * 2022-07-04 2024-01-05 上海优卡迪生物医药科技有限公司 表达重组抗原蛋白的饲养细胞及其制备方法和应用
CN115725509B (zh) * 2022-12-09 2025-07-04 上海贝斯昂科生物科技有限公司 一种基因工程细胞的制备及其在nk细胞体外扩增中的应用
KR102669705B1 (ko) * 2023-02-24 2024-06-10 이엔셀 주식회사 제대혈 유래 자연 살해 세포의 확장배양방법
CN116286666B (zh) * 2023-05-15 2023-08-04 成都云测医学生物技术有限公司 滋养层细胞及其制备方法、应用和扩增nk细胞的方法
AU2024351310A1 (en) * 2023-09-25 2026-03-26 Legend Biotech Ireland Limited Modified immune cells and calcineurin inhibitors and uses thereof
GB202317912D0 (en) * 2023-11-23 2024-01-10 Univ College Cardiff Consultants Ltd Viral-based immuno therapeutic
KR20250153112A (ko) * 2024-04-16 2025-10-24 주식회사 유씨아이테라퓨틱스 자연살해세포의 증폭 및 형질 도입 효율 증진용 피더 세포

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4749620A (en) 1984-02-15 1988-06-07 Massachusetts Institute Of Technology Encapsulated active material system
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
JPH0628570B2 (ja) 1986-02-13 1994-04-20 雪印乳業株式会社 カプセル体の製造方法及び装置
EP0301777A1 (en) 1987-07-28 1989-02-01 Queen's University At Kingston Multiple membrane microencapsulation
US5089272A (en) 1989-03-29 1992-02-18 Snow Brand Milk Products Co., Ltd. Process for producing capsules having a permeability-controllable membrane
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5578442A (en) 1992-03-23 1996-11-26 Vivorx, Inc. Graft copolymers of polycationic species and water-soluble polymers, and use therefor
ATE218893T1 (de) 1993-08-12 2002-06-15 Neurotech Sa Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten
WO2012131419A1 (en) * 2011-03-25 2012-10-04 Txcell Method for using regulatory t cells in therapy
WO2012146702A1 (en) * 2011-04-28 2012-11-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for preparing accessory cells and uses thereof for preparing activated nk cells
EP2893003B1 (en) * 2012-09-04 2021-03-31 Inven2 AS Selective and controlled expansion of educated nk cells
EP3021853A1 (en) * 2013-07-18 2016-05-25 Baylor College Of Medicine Method of enhancing potency of immune cells
EP3223856B1 (en) * 2014-10-27 2025-09-24 University of Central Florida Research Foundation, Inc. Methods and compositions for natural killer cells
GB201616237D0 (en) * 2016-09-23 2016-11-09 Univ Oslo Hf Modulation of function of immune effector cells

Similar Documents

Publication Publication Date Title
JP2022513116A5 (https=)
US20220296690A1 (en) Engineered t cells and uses therefor
JP7770188B2 (ja) 養子細胞療法のための標的共刺激を提供する受容体
US20220348631A1 (en) Receptors providing targeted costimulation for adoptive cell therapy
Hornig et al. Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy
CN112639102A (zh) 抗间皮素嵌合抗原受体(car)构建体及其用途
Karches et al. Bispecific antibodies enable synthetic agonistic receptor-transduced T cells for tumor immunotherapy
KR20200099137A (ko) 세포 요법 및 감마 세크레타제 억제제의 조합
CN109651511B (zh) 一种靶向bcma的嵌合抗原受体及其应用
JP2024023228A5 (https=)
KR20200015567A (ko) Mage-a4 유래 펩티드를 인식하는 항원 결합성 단백질
JPWO2020104676A5 (https=)
CA3032054A1 (en) Combination therapies of chimeric antigen receptors and pd-1 inhibitors
CN113795262A (zh) 人源化抗dll3嵌合抗原受体及其用途
US12459983B2 (en) Engineered immune cells with receptor signal strength modulated by a hinge
JPWO2021071962A5 (https=)
Battin et al. Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
KR20250169609A (ko) 림포톡신 β 수용체 작용제를 이용한 암 치료 방법
WO2023155852A1 (zh) 经修饰的免疫效应细胞及其用途
WO2026019829A1 (en) Compositions and methods for stimulating t cells used in cell therapy with a bispecific bridging molecule
JP2026513920A (ja) リンホトキシンベータ受容体アゴニストを用いてがんを処置する方法
US20250121007A1 (en) Compositions for the treatment of cancer
KR20250089551A (ko) 입양 세포 요법과 표적 면역사이토카인을 조합하여 이용한 암 치료 방법
KR20260013488A (ko) 면역 이펙터 세포 및 이의 용도
HK40041676A (en) Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof